Page 32 - Read Online

129. Mazzoni E, Tognon M, Martini F, Taronna A, Corallini A, Barbanti- 149. Liang Y, Ganem D. Lytic but not latent infection by Kaposi’s sarcoma-
Brodano G, Guerra G, Carandina G, Casali F, Rezza G, Pizzo G, associated herpesvirus requires host CSL protein, the mediator of
Valdarchi C. Simian virus 40 (SV40) antibodies in elderly subjects. Notch signaling. Proc Natl Acad Sci U S A 2003;100:8490-5.
J Infect 2013;67:356-8. 150. Curry CL, Reed LL, Golde TE, Miele L, Nickoloff BJ, Foreman
130. Martini F, Mazzoni E, Corallini A, Taronna A, Querzoli P, Magri KE. Gamma secretase inhibitor blocks Notch activation and induces
E, Marci R, Dolcetti R, Rezza G, Barbanti-Brodano G, Tognon apoptosis in Kaposi’s sarcoma tumor cells. Oncogene 2005;24:6333-44.
M. Breast cancer and simian virus 40 infection. Epidemiology 151. Ansieau S, Strobl LJ, Leutz A. Activation of the Notch-regulated
2013;24:464-5. transcription factor CBF1/RBP-Jkappa through the 13SE1A
131. Mazzoni E, Martini F, Corallini A, Taronna A, Barbanti-Brodano G, oncoprotein. Genes Dev 2001;15:380-5.
Querzoli P, Magri E, Rotondo JC, Dolcetti R, Vaccher E, Tognon M. 152. Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI,
Serologic investigation on undifferentiated nasopharyngeal carcinoma Carbone M. SV40 and the pathogenesis of mesothelioma. Semin
and simian virus 40 infection. Head Neck 2014;doi: 10.1002/hed.23879. Cancer Biol 2001;11:63-71.
132. Comar M, Wong C, Tognon M, Butel JS. Neutralizing and 153. Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a
IgG antibodies against simian virus 40 in healthy pregnant women in novel activity of SV40 required for growth of SV40-transformed
Italy. PLoS One 2014;9:e110700. human mesothelial cells. Oncogene 2003;22:81-9.
133. Borgna-Pignatti C, Mazzoni E, Felletti M, Turla G, Malaventura 154. Zhang L, Qi F, Gaudino G, Strianese O, Yang H, Morris P, Pass
C, Cappellini MD, Cianciulli P, Forni GL, Corallini A, Martini F, HI, Nerurkar VR, Bocchetta M, Carbone M. Tissue tropism of
Tognon M. Antibodies reacting with simian virus 40 mimotopes SV40 transformation of human cells: role of the viral regulatory
in serum samples from patients with thalassaemia major. Blood region and of cellular oncogenes. Genes Cancer 2010;1:1008-20.
Transfus 2014;12:464-70. 155. Ali-Seyed M, Laycock N, Karanam S, Xiao W, Blair ET, Moreno
134. Zur Hausen H. Papillomaviruses in the causation of human CS. Cross-platform expression profiling demonstrates that SV40
cancers-a brief historical account. Virology 2009;384:260-5. small tumor antigen activates Notch, Hedgehog, and Wnt signaling
135. Franceschi S. The IARC commitment to cancer prevention: the in human cells. BMC Cancer 2006;6:54.
example of papillomavirus and cervical cancer. Recent Results 156. Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B, Li XD,
Cancer Res 2005;166:277-97. Zhao J, Chen LP, Xing XM, Tang SF, Lin YC, Lai YD, Yang P, Zeng
136. DiMaio D, Liao JB. Human papillomaviruses and cervical cancer. JL, Xiao Q, Zeng XW, Lin ZN, Zhuang ZX, Zhuang SM, Chen W.
Adv Virus Res 2006;66:125-59. Upregulation of miR-27a contributes to the malignant transformation
137. Gjoerup O, Chang Y. Update on human polyomaviruses and of human bronchial epithelial cells induced by SV40 small T
cancer. Adv Cancer Res 2010;106:1-51. antigen. Oncogene 2011;30:3875-86.
138. Moody CA, Laimins LA. Human papillomavirus oncoproteins: 157. Goetz F, Tzeng YJ, Guhl E, Merker J, Graessmann M, Graessmann
pathways to transformation. Nat Rev Cancer 2010;10:550-60. A. The SV40 small t-antigen prevents mammary gland differentiation
139. Martin D, Gutkind JS. Human tumor-associated viruses and new and induces breast cancer formation in transgenic mice; truncated
insights into the molecular mechanisms of cancer. Oncogene large T-antigen molecules harboring the intact p53 and pRb binding
2008;27 Suppl 2:S31-42. region do not have this effect. Oncogene 2001;20:2325-32.
140. IARC Working Group on the Evaluation of Carcinogenic Risks 158. Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver
to Humans. Human papillomaviruses. Lyon: IARC Monogr Eval MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W,
Carcinog Risks Hum. 2007. p. 1-636. Liu ZY, Calvo A, Couldrey C. The C3(1)/SV40 T-antigen transgenic
141. Zur Hausen H. Papillomaviruses causing cancer: evasion from host- mouse model of mammary cancer: ductal epithelial cell targeting with
cell control in early events in carcinogenesis. J Natl Cancer Inst multistage progression to carcinoma. Oncogene 2000;19:1020-7.
2000;92:690-8. 159. Hachana M, Trimeche M, Ziadi S, Amara K, Korbi S. Evidence
142. Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim for a role of the Simian Virus 40 in human breast carcinomas.
A, Castle PE, Solomon D, Burk R, Proyecto Epidemiologico Breast Cancer Res Treat 2009;113:43-58.
Guanacaste Group. Rapid clearance of human papillomavirus and 160. Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff
implications for clinical focus on persistent infections. J Natl Cancer MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee
Inst 2008;100:513-7. EY, Medina D, Shih JH, Green JE. Identification of an integrated
143. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura SV40 T/t-antigen cancer signature in aggressive human breast,
RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco prostate, and lung carcinomas with poor prognosis. Cancer Res
EL. Persistent human papillomavirus infection as a predictor of 2007;67:8065-80.
cervical intraepithelial neoplasia. JAMA 2001;286:3106-14. 161. Lathion S, Schaper J, Beard P, Raj K. Notch1 can contribute to viral-
144. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah induced transformation of primary human keratinocytes. Cancer
KV, Snijders PJ, Meijer CJ, International Agency for Research on Res 2003;63:8687-94.
Cancer Multicenter Cervical Cancer Study Group. Epidemiologic 162. Daniel B, Rangarajan A, Mukherjee G, Vallikad E, Krishna S. The
classification of human papillomavirus types associated with link between integration and expression of human papillomavirus
cervical cancer. N Engl J Med 2003;348:518-27. type 16 genomes and cellular changes in the evolution of cervical
145. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human intraepithelial neoplastic lesions. J Gen Virol 1997;78:1095-101.
papillomavirus types in invasive cervical cancer worldwide: a 163. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-
meta-analysis. Br J Cancer 2003;88:63-73. Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the
146. Martini F, Iaccheri L, Martinelli M, Martinello R, Grandi E, Mollica human cervix. Proc Natl Acad Sci U S A 1995;92:6414-8.
G, Tognon M. Papilloma and polyoma DNA tumor virus sequences in 164. Tripathi R, Rath G, Jawanjal P, Sharma S, Singhal P, Bhambhani S,
female genital tumors. Cancer Invest 2004;22:697-705. Hussain S, Bharadwaj M. Clinical impact of de-regulated Notch-1
147. Hayward SD. Viral interactions with the Notch pathway. Semin and Notch-3 in the development and progression of HPV-associated
Cancer Biol 2004;14:387-96. different histological subtypes of precancerous and cancerous
148. Hsieh JJ, Hayward SD. Masking of the CBF1/RBPJ kappa lesions of human uterine cervix. PLoS One 2014;9:e98642.
transcriptional repression domain by Epstein-Barr virus EBNA2. 165. Veeraraghavalu K, Pett M, Kumar RV, Nair P, Rangarajan A, Stanley
Science 1995;268:560-3. MA, Krishna S. Papillomavirus-mediated neoplastic progression is

22
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ Issue 1 ¦ January 15, 2016 ¦